Publisher： Bentham Science Publishers
E-ISSN： 1873-4316|10|2|154-160
ISSN： 1389-2010
Source： Current Pharmaceutical Biotechnology, Vol.10, Iss.2, 2009-02, pp. : 154-160
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
mTOR pathway inhibitors in cancer therapy: moving past rapamycin
Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. :
Inhibitors of mTOR pathway for cancer therapy, moving on from rapalogs to TORKinibs
Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. :
mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy
Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. :
PARP Inhibitors: An Interesting Pathway also for Non-Small Cell Lung Cancer?
Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. :